Full-Time

Senior Scientist

R&D

Posted on 9/20/2024

Natera

Natera

1,001-5,000 employees

Genetic testing and diagnostics solutions provider

Biotechnology
Healthcare

Compensation Overview

$106.2k - $132.7kAnnually

Senior

Austin, TX, USA + 2 more

More locations: San Carlos, CA, USA | Remote in USA

Position can work out of San Carlos, CA, Austin, TX, or remote.

Category
Genomics
Biology & Biotech
Requirements
  • PhD degree in Molecular Biology, Biochemistry, or related field with 4+ years industry experience in developing NGS based assays from concept to commercialization. Masters or Bachelors candidates with 6+ years or 8+ years, respectively, may also be considered.
  • Experience with assay workflow development, optimization required.
  • Demonstrated experience with standard processes and approaches for IVD verification and validation required.
  • Experience in IVD development for NGS applications is required.
  • Knowledge of quality and regulatory requirements (ISO 13485, 21 CFR Part 820, Risk Analysis ISO 14971) is highly required.
  • Experience in preparing technical summaries for regulatory submission (including ex-US) is highly desirable.
  • Knowledge of DOE and Statistical methods highly desirable.
  • Solid skills in document writing; development of reports, plans, work instructions, technology transfer from R&D to manufacturing required.
  • Comfortable in a role of technical leader for a project, willingness to direct and manage project activities for team members as well as function as an individual contributor to the team.
  • Willing to analyze results from both the perspective of product development and requirements for robust products and the perspective of the customer.
  • Detail-oriented, organized, ability to plan, design and oversee execution of protocols.
  • Analytical, detail oriented, organized, efficient, problem solver.
  • Must have a desire to be part of a fast-paced and dynamic development environment.
  • Excellent communication skills, both written and verbal.
Responsibilities
  • Contribute to experimental study design and oversee documentation, execution and data analysis of experiments for various development projects for FDA-regulated products (510K, de-novo, CDx).
  • Accountable for preparing technical summaries for submission to regulatory bodies, such as the FDA, PMDA, IVDR, etc.
  • Closely coordinate with matrixed teams on projects throughout design-controlled product development phases, contribute to core teams, and work with cross-functional leads from Product and Program Management to deliver development milestones for best-in-class IVD products.
  • Responsible for owning, creating and maintaining several design control deliverables such as Design Inputs/Outputs, Trace Matrix, FMEAs, development and design verification and validation study plans, stability plans, among others, as applicable.
  • Assist with external-facing discussions and collaborations with Biopharma partners and regulatory bodies.
  • Analysis and presentation of complex datasets with the support of bioinformatic scientists.
  • Contribute to the overall success of projects; anticipate problems to minimize issues and work to resolve any issues to mitigate impact on success of project.
  • Mentor, direct and assist junior scientific staff setting an example for good scientific practices.
  • Write experimental reports, summaries and protocols for supervisors, project needs, and other teams as appropriate.
  • Assist with strategy, risk management, documentation, and improvement of processes, as applicable.

Natera specializes in genetic testing and diagnostics, focusing on advanced testing solutions for various medical needs. Their main technology is cell-free DNA (cfDNA) testing, which analyzes small DNA fragments in the blood to detect molecular residual disease (MRD) in cancer patients, aiding in treatment decisions. They also offer the Signatera test, a custom ctDNA test for cancer patients, accessible through their GI Expanded Access Program. In addition to oncology, Natera provides testing for organ health in transplant patients and offers a range of women's health tests, including the Panorama NIPT for prenatal screening. Natera's services are provided to healthcare providers, hospitals, and directly to patients, generating revenue through testing kits and services, often reimbursed by insurance. Their goal is to enhance patient care through precise genetic insights and support.

Company Stage

IPO

Total Funding

$149.9M

Headquarters

Austin, Texas

Founded

2004

Growth & Insights
Headcount

6 month growth

9%

1 year growth

25%

2 year growth

66%
Simplify Jobs

Simplify's Take

What believers are saying

  • Increased adoption of liquid biopsy techniques boosts demand for Natera's cfDNA tests.
  • AI integration enhances accuracy and speed of Natera's cfDNA analysis.
  • Growing personalized medicine trend aligns with Natera's customized genetic tests.

What critics are saying

  • Hindenburg report accuses Natera of deceptive sales practices, risking legal challenges.
  • New Prospera Heart features may face slow adoption by healthcare providers.
  • Fetal RhD NIPT demand may drop post-RhIg shortage, affecting future sales.

What makes Natera unique

  • Natera's Signatera test offers personalized ctDNA analysis for cancer patients.
  • Prospera Heart test uses unique Donor Quantity Score for transplant rejection detection.
  • Panorama NIPT test is a leader in non-invasive prenatal testing with 2 million tests.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Flexible medical plans

Investment options

Time off

Workplace perks

INACTIVE